Table 2: Clinical laboratory measurements of the study groups.
Clinical Laboratory Measurement | Reference Interval | CTL (n = 12) Mean ± SD Median (P25-P75) |
HT (n = 14) Mean ± SD Median (P25-P75) |
STR (n = 13) Mean ± SD Median (P25-P75) |
P-value† |
HbA1c (%) |
< 6.5 |
5.6 ± 0.4 5.5 (5.4-5.8) |
6.0 ± 1.0 5.7 (5.5-63) |
6.5 ± 1.1 6.1 (5.9-6.5) |
0.01* |
Glucose (mg/dL) |
65-99 |
91.6 ± 11.7 87.5 (84.5-97) |
128.1 ± 72.5 109 (103-127) |
169.5 ± 67.5 149 (116-180) |
< 0.001* |
Calcium (mg/dL) |
8.7-10.3 |
9.6 ± 0.4 9.7 (9.6-9.9) |
9.8 ± 0.6 9.9 (9.4-10.0) |
9.1 ± 0.5 9.0 (8.8-9.4) |
< 0.01‡* |
Albumin (g/dL) |
3.5-5.5 |
4.4 ± 0.3 4.4 (4.2-4.6) |
4.5 ± 0.3 4.4 (4.3-4.6) |
4.0 ± 0.4 4.0 (3.7-4.2) |
< 0.01‡* |
CO2 (mmol/L) |
18-29 |
28.7 ± 1.2 28.5 (28-30) |
28.3 ± 1.0 28 (28-29) |
25.5 ± 2.9 26 (23-27) |
< 0.01* |
Chloride (mmol/L) |
98-110 |
99.6 ± 1.8 99 (98-101) |
99.5 ± 1.6 99 (99-100) |
95.7 ± 25.9 103 (101-104) |
0.01* |
CTL: Control Patients; HT: Hypertensive Patients Receiving Treatment; STR: Ischemic Stroke patients.
†Kruskal-Wallis test was performed to calculate p-values unless otherwise specified; ‡One-way ANOVA test was performed to calculate p-values; *Statistically significant (p < 0.05).